Bevacizumab biosimilar (Hetero Drugs) |
|
Approved |
Hetero Drugs |
Cizumab |
India |
Colorectal Neoplasms |
Hetero Drugs |
2016-01-01 |
Colorectal Neoplasms |
Details
|
Ziv-aflibercept |
BAY-865321; AVE-0005 |
Approved |
Regeneron Pharmaceuticals Inc, Sanofi |
Zaltrap |
Japan |
Colorectal Neoplasms |
Sanofi |
2012-08-03 |
Ovarian Neoplasms; Solid tumours; Ascites; Lung Diseases; Prostatic Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Lymphoma; Neoplasm Metastasis |
Details
|
Bevacizumab biosimilar (Boan Biopharma) |
LY-01008 |
Approved |
Shandong Boan Biotechnology Co Ltd |
博优诺 |
Mainland China |
Carcinoma, Hepatocellular |
Shandong Boan Biotechnology Co Ltd |
2021-05-07 |
Glioblastoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular |
Details
|
Bevacizumab biosimilar (Zydus Cadila) |
|
Approved |
Zydus Cadila |
Bryxta |
India |
Carcinoma, Non-Small-Cell Lung |
Zydus Cadila |
2017-01-01 |
Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Dr. Reddy's Laboratories) |
|
Approved |
Dr. Reddy’S Laboratories Ltd |
Versavo |
India |
Glioma; Carcinoma, Renal Cell; Peritoneal Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms |
Dr. Reddy’S Laboratories Ltd |
2019-01-01 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Glioma; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Ranibizumab biosimilar (Intas Biopharmaceuticals) |
|
Approved |
Intas Biopharmaceuticals |
Razumab |
India |
Macular Degeneration |
Intas Biopharmaceuticals |
2015-01-01 |
Macular Degeneration |
Details
|
Bevacizumab Biosimilar (AXXO) |
|
Approved |
Axxo |
|
Russian Federation |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Axxo |
2013-01-01 |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Elea) |
|
Approved |
Elea |
Lumiere |
Argentina |
Macular Degeneration |
Elea |
2018-09-01 |
Macular Degeneration |
Details
|
Neovasculgen |
PI-VEGF165 |
Approved |
Human Stem Cells Institute |
Neovasculgen |
Russian Federation |
Peripheral Arterial Disease |
Human Stem Cells Institute |
2011-12-07 |
Peripheral Arterial Disease |
Details
|
Bevacizumab biosimilar (Biocad) |
BCD-021 |
Approved |
Biocad |
Avegra |
Russian Federation |
Glioblastoma; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Biocad |
2015-11-25 |
Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Conbercept |
FP-3; KH-902 |
Approved |
Chengdu Kanghong Biotechnologies Co Ltd |
朗沐, Langmu |
Mainland China |
Macular Degeneration |
Chengdu Kanghong Biotechnologies Co Ltd |
2013-11-27 |
Macular Edema; Vision Disorders; Wet Macular Degeneration; Diabetic macular oedema; Retinoblastoma; Corneal Neovascularization; Macular Degeneration; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetes Mellitus |
Details
|
Bevacizumab biosimilar (Intas Pharmaceuticals) |
|
Approved |
Intas Biopharmaceuticals |
Bevatas |
|
|
|
|
Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Biocon/Mylan) |
MYL-1402O |
Approved |
Biocon |
KRABEVA |
EU |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms |
Mylan Ire Healthcare Ltd |
2017-01-01 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Breast Neoplasms; Brain Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Ranibizumab biosimilar (Samsung Bioepis) |
SB-11 |
Approved |
Samsung Bioepis |
BYOOVIZ |
United States |
Macular Degeneration; Macular Edema; Choroidal Neovascularization |
null, Samsung Bioepis Co Ltd |
2021-08-18 |
Macular Edema; Wet Macular Degeneration; Macular Degeneration; Choroidal Neovascularization; Diabetic Retinopathy |
Details
|
Bevacizumab biosimilar (Innovent Biologics) |
IBI-305; IBI305; IBI 305 |
Approved |
Innovent Biologics(Suzhou) Co Ltd |
达攸同, BYVASDA |
Mainland China |
Carcinoma, Hepatocellular |
Innovent Biologics(Suzhou) Co Ltd |
2020-06-17 |
Glioblastoma; Colorectal Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Jiangsu Hengrui Medicine) |
BP-102 |
Approved |
Jiangsu Hengrui Medicine Co Ltd |
|
Mainland China |
Rectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Suzhou Suncadia Biopharmaceuticals Co Ltd |
2021-06-22 |
Solid tumours; Rectal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Betta/Mabworks) |
MIL-60 |
Approved |
Institute Of Basic Medicine, Chinese Academy Of Medical Sciences, Beijing Mabworks Biotech Co Ltd |
贝安汀 |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Betta Pharmaceuticals Co Ltd |
2021-11-24 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular |
Details
|
Bevacizumab biosimilar (TOT Biopharm) |
TAB-008; TOT-102; TAB008; TOT102 |
Approved |
Tot Biopharm Co Ltd |
朴欣汀, Pusintin |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Tot Biopharm Co Ltd |
2021-12-01 |
Glioblastoma; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Aflibercept |
BAT-86-5321; BAY-865321 |
Approved |
Regeneron Pharmaceuticals Inc, Bayer Ag |
Eylea |
Mainland China |
Macular Degeneration; Macular Edema |
Bayer Australia Ltd |
2011-11-18 |
Diabetes Complications; Neoplasm Metastasis; Retinopathy of Prematurity; Retinal Vein Occlusion; Macular Degeneration; Diabetic Retinopathy; Diabetes Mellitus; Retinal Degeneration; Colorectal Neoplasms; Diabetes Mellitus, Type 1; Prostatic Neoplasms; Wet Macular Degeneration; Diabetic macular oedema; Myopia, Degenerative; Retinal Diseases; Glaucoma, Neovascular; Diabetes Mellitus, Type 2; Macular Edema |
Details
|
Bevacizumab biosimilar (Shanghai Henlius Biotech) |
HLX-04; HLX04-O |
Approved |
Shanghai Henlius Biotech Co Ltd |
|
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Shanghai Henlius Biopharmaceuticals Co Ltd |
2021-11-30 |
Solid tumours; Carcinoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Macular Degeneration |
Details
|
Ranibizumab biosimilar (Senju) |
GBS-007; OT-701; SJP-0133 |
Approved |
Senju Pharmaceutical Co Ltd |
|
Japan |
Macular Degeneration |
Senju Pharmaceutical Co Ltd |
2021-09-27 |
Macular Degeneration |
Details
|
Bevacizumab biosimilar (Bio-Thera Solutions) |
BAT-1706 |
Approved |
Bio-Thera Solutions Ltd |
普贝希 |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Beigene Ltd, Bio-Thera Solutions Ltd |
2021-11-17 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Glioblastoma; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular |
Details
|
Ranibizumab |
rhuFab-V2; Y-0317; RFB-002; RG-6321; RG-3645; rhu-Fab-VEG; AMD-rhuFab-V2; AMD-Fab |
Approved |
Novartis Pharma Ag, Genentech Inc |
Lucentis, 诺适得, Susvimo |
Japan |
Diabetic macular oedema |
Novartis Pharma Ag |
2006-06-30 |
Macular Edema; Vision Disorders; Glaucoma, Neovascular; Neovascularization, Pathologic; Myopia, Degenerative; Retinal Diseases; Diabetic macular oedema; Wet Macular Degeneration; Retinal Degeneration; Macular Degeneration; Choroidal Neovascularization; Diabetic Retinopathy; Retinal Vein Occlusion; Diabetes Mellitus; Myopia; Retinopathy of Prematurity |
Details
|
Faricimab |
RG-7716; RO-6867461 |
Approved |
F. Hoffmann-La Roche Ltd, Genentech Inc |
Vabysmo |
United States |
Diabetic macular oedema; Wet Macular Degeneration |
Genentech Inc |
2022-01-28 |
Macular Edema; Diabetic macular oedema; Wet Macular Degeneration; Diabetes Mellitus; Macular Degeneration; Retinal Vein Occlusion |
Details
|
Bevacizumab biosimilar (mAbixience) |
MB02; BEVZ-92; BEVZ92-MB02 |
Approved |
Mabxience |
Alymsys |
EU |
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Breast Neoplasms; Uterine Cervical Neoplasms; Colorectal Neoplasms; Ovarian Neoplasms |
Stada Arzneimittel Ag, Mabxience Sa |
2013-10-25 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Allergan/Amgen) |
ABP-215 |
Approved |
Amgen Inc |
Mvasi |
Japan |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Glioblastoma; Carcinoma, Renal Cell |
Daiichi Sankyo Co Ltd |
2017-09-14 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Samsung Bioepis) |
SB-8; SP-8 |
Approved |
Samsung Bioepis |
Aybintio |
EU |
Carcinoma, Ovarian Epithelial; Uterine Cervical Neoplasms; Peritoneal Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Carcinoma, Renal Cell |
Samsung Bioepis Nl Bv |
2020-08-19 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Pfizer) |
PF-6439535; PF-06439535 |
Approved |
Pfizer Inc |
Zirabev |
United States |
Peritoneal Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms |
Pfizer Inc |
2019-02-14 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab |
G180CU; RO-4876646; RG-435; NSC-704865; G180CL; R-435; G180DL |
Approved |
Genentech Inc |
安维汀, Avastin |
Mainland China |
Carcinoma, Hepatocellular |
Roche Pharmaceutical Co Ltd |
2004-02-26 |
Peritoneal Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Macular Degeneration; Carcinoma, Hepatocellular; Neoplasm Metastasis; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Glioma; Fallopian Tube Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Brain Neoplasms; Sarcoma; Breast Neoplasms; Multiple Myeloma; Glioblastoma; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Liver Neoplasms |
Details
|